|
1) Third Report of the National Cholesterol Education Program (NCEP)Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)final report. Circulation. 2002; 106: 3143-421
|
|
|
|
2) 動脈硬化性疾患予防ガイドライン2007年版. 日本動脈硬化学会. 2007
|
|
|
|
|
|
3) Iso H, Naito Y, Sato S, et al. Serum triglycerides and risk of coronary heart disease among Japanese men and women. Am J Epidemiol. 2001; 153: 490-9
|
|
|
|
|
4) Sugimoto K, Isobe K, Kawakami Y, et al. The relationship between non-HDL cholesterol and other lipid parameters in Japanese subjects. Atheroscler Thromb. 2005; 12: 107-10
|
|
|
|
|
|
5) Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial. Lancet. 2005; 366: 1849-61. Erratum in: Lancet. 2006; 368: 1415
|
|
|
|
|
|
6) Secondary prevention by raising HDL cholesterol and reducing triglycerides in patients with coronary artery disease: the Bezafibrate Infarction Prevention (BIP) study. Circulation. 2000; 102: 21-7
|
|
|
|
|